SV2006002221A - Hexadecasacaridos biotinilados, su preparacion y su utilizacion - Google Patents

Hexadecasacaridos biotinilados, su preparacion y su utilizacion

Info

Publication number
SV2006002221A
SV2006002221A SV2005002221A SV2005002221A SV2006002221A SV 2006002221 A SV2006002221 A SV 2006002221A SV 2005002221 A SV2005002221 A SV 2005002221A SV 2005002221 A SV2005002221 A SV 2005002221A SV 2006002221 A SV2006002221 A SV 2006002221A
Authority
SV
El Salvador
Prior art keywords
hexadecasacaridos
biotinilados
preparation
alcoxi
oso3
Prior art date
Application number
SV2005002221A
Other languages
English (en)
Inventor
Duchaussoy Philippe
Herault Jean Pascal
Herbert Jean Marc
Savi Pierre
Maurice Petitou
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2006002221(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SV2006002221A publication Critical patent/SV2006002221A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)

Abstract

NUEVOS HEXACARIDO BIOTINILADOS DE LA FORMULA GENERAL I SIGUIENTE; VER FORMULA;EN LA CUAL:BIOT ES UN DERIVADO DE BIOTINA;R, R1 Y R2 REPRESENTAN, DE FORMA INDEPENDIENTE ENTRE SI, UN RESTO ALCOXI-(C1-C6) U -OSO3;-R3 REPRESENTA UN RESTO ALCOXI -(C1-C6) U -OSO3; O R3 CONSTITUYE UN PUENTE -O-CH2-;ASI COMO SUS SALES FARMACEUTICAMENTE ACEPTABLES
SV2005002221A 2004-09-09 2005-09-08 Hexadecasacaridos biotinilados, su preparacion y su utilizacion SV2006002221A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Publications (1)

Publication Number Publication Date
SV2006002221A true SV2006002221A (es) 2006-01-13

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002221A SV2006002221A (es) 2004-09-09 2005-09-08 Hexadecasacaridos biotinilados, su preparacion y su utilizacion

Country Status (39)

Country Link
US (3) US20070270342A1 (es)
EP (1) EP1791872B1 (es)
JP (1) JP5108519B2 (es)
KR (1) KR101223364B1 (es)
CN (1) CN101039963B (es)
AR (1) AR051286A1 (es)
AT (1) ATE420118T1 (es)
AU (1) AU2005284080B2 (es)
BR (1) BRPI0515078A (es)
CA (1) CA2577258C (es)
CY (1) CY1109126T1 (es)
DE (1) DE602005012287D1 (es)
DK (1) DK1791872T3 (es)
EA (1) EA012587B1 (es)
EC (1) ECSP077272A (es)
ES (1) ES2320576T3 (es)
FR (1) FR2874924B1 (es)
GT (1) GT200500250A (es)
HK (1) HK1113686A1 (es)
HN (1) HN2005000518A (es)
HR (1) HRP20090180T1 (es)
IL (1) IL181569A (es)
MA (1) MA28859B1 (es)
MX (1) MX2007002875A (es)
MY (1) MY140666A (es)
NI (1) NI200700063A (es)
NO (1) NO20071754L (es)
PA (1) PA8644201A1 (es)
PE (1) PE20060663A1 (es)
PL (1) PL1791872T3 (es)
PT (1) PT1791872E (es)
RS (1) RS50762B (es)
SI (1) SI1791872T1 (es)
SV (1) SV2006002221A (es)
TN (1) TNSN07053A1 (es)
TW (1) TW200612970A (es)
UY (1) UY29102A1 (es)
WO (1) WO2006030104A1 (es)
ZA (1) ZA200702255B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
US20100279960A1 (en) 2010-11-04
EA200700594A1 (ru) 2007-08-31
NI200700063A (es) 2008-03-07
NO20071754L (no) 2007-04-02
SI1791872T1 (sl) 2009-06-30
US8557968B2 (en) 2013-10-15
AU2005284080B2 (en) 2011-10-13
TNSN07053A1 (fr) 2008-06-02
US8703738B2 (en) 2014-04-22
PA8644201A1 (es) 2006-05-16
IL181569A (en) 2011-08-31
DK1791872T3 (da) 2009-05-04
TW200612970A (en) 2006-05-01
JP2008512538A (ja) 2008-04-24
BRPI0515078A (pt) 2008-07-01
IL181569A0 (en) 2007-07-04
PL1791872T3 (pl) 2009-06-30
JP5108519B2 (ja) 2012-12-26
EA012587B1 (ru) 2009-10-30
ATE420118T1 (de) 2009-01-15
WO2006030104A1 (fr) 2006-03-23
PT1791872E (pt) 2009-03-27
CA2577258A1 (fr) 2006-03-23
FR2874924B1 (fr) 2006-12-01
AR051286A1 (es) 2007-01-03
EP1791872A1 (fr) 2007-06-06
MY140666A (en) 2010-01-15
CY1109126T1 (el) 2014-07-02
ES2320576T3 (es) 2009-05-25
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
UY29102A1 (es) 2006-04-28
HN2005000518A (es) 2009-06-01
US20070270342A1 (en) 2007-11-22
CA2577258C (fr) 2013-05-21
CN101039963B (zh) 2011-07-27
ECSP077272A (es) 2007-03-29
CN101039963A (zh) 2007-09-19
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
US20130004551A1 (en) 2013-01-03
MX2007002875A (es) 2007-05-16
KR101223364B1 (ko) 2013-01-16
PE20060663A1 (es) 2006-08-21
AU2005284080A1 (en) 2006-03-23
GT200500250A (es) 2006-04-10
MA28859B1 (fr) 2007-09-03
KR20070051887A (ko) 2007-05-18
EP1791872B1 (fr) 2009-01-07
HK1113686A1 (en) 2008-10-10
HRP20090180T1 (en) 2009-05-31

Similar Documents

Publication Publication Date Title
SV2006002221A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
MY147786A (en) Substituted morpholine and thiomorpholine derivatives
TW200613101A (en) Tool box hanging base
AR048778A1 (es) Derivados de pirrolidinilo como inhibidores de 11-beta hidroxiesteroide deshidrogenasa
RS52632B (en) S-TRIAZOLYL ALFA-MERCAPTOACETANILIDE AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE
PA8649401A1 (es) Analogos de anilino-pirimidina
AR048448A1 (es) Derivados de difluormetanosulfonamida y su uso como herbicida
DE60321906D1 (de) Management des stimulationserfolgs bei mehrkammerstimulation
ATE483000T1 (de) Naphtalin-amidin-imide
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
RS52843B (en) THE NEW IS THE HYDROGEN SULPHATE
HN2003000285A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
ECSP099565A (es) Compuesto de 2-amino pirimidina
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
MXPA05009282A (es) Derivados de anilina sustituidos.
SG171472A1 (en) Substituted aniline derivatives
CR8185A (es) Pirimidinas 2- sustituidas
EA200801306A1 (ru) Сульфамоилсульфонатные пролекарства
PA8564801A1 (es) Derivados de fenilglicina solubles en agua
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
UY27560A1 (es) Compuestos hexaciclicos-
DOP2005000173A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion terapeutica.
UY28180A1 (es) Agentes de despigmentación
EA200700254A1 (ru) Димерные производные пипередина